Castle Biosciences (CSTL) Stock Forecast & Price Target

$31.47

+0.94 (+3.08%)

(As of 09/20/2024 ET)

Castle Biosciences - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy
Based on 5 Analyst Ratings

Based on 5 Wall Street analysts who have issued ratings for Castle Biosciences in the last 12 months, the stock has a consensus rating of "Buy." Out of the 5 analysts, 5 have given a buy rating for CSTL.

Consensus Price Target

$32.80
4.23% Upside

High Forecast	$37.00
Average Forecast	$32.80
Low Forecast	$25.00

According to the 5 analysts' twelve-month price targets for Castle Biosciences, the average price target is $32.80. The highest price target for CSTL is $37.00, while the lowest price target for CSTL is $25.00. The average price target represents a forecasted upside of 4.23% from the current price of $31.47.

Type	Current Forecast 9/23/23 to 9/22/24	1 Month Ago 8/24/23 to 8/23/24	3 Months Ago 6/25/23 to 6/24/24	1 Year Ago 9/23/22 to 9/23/23
Consensus Rating	Buy	Buy	Buy	Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	5 Buy rating(s)	5 Buy rating(s)	4 Buy rating(s)	4 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$32.80	$32.80	$31.00	$32.29
Forecasted Upside	4.23% Upside	51.26% Upside	47.79% Upside	67.29% Upside

Get Castle Biosciences Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CSTL and its competitors with MarketBeat's FREE daily newsletter.

War on Elon Escalates… (Ad)

Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adoption of this technology for decades. By doing so he has put himself in the crosshairs of an ideological war with the global elites. And yet, while this new technology threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

Click here to learn how you can benefit from its widespread distribution.

CSTL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CSTL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Castle Biosciences Stock vs. The Competition

Type	Castle Biosciences	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.78	2.50
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	4.23% Upside	875.92% Upside	7.41% Upside
News Sentiment Rating	Neutral News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
8/6/2024	Stephens 4 of 5 stars	Reiterated Rating	Overweight ➝ Overweight	$37.00 ➝ $37.00	+45.04%
8/6/2024	Robert W. Baird 2 of 5 stars	Boost Target	Outperform ➝ Outperform	$34.00 ➝ $37.00	+69.34%
3/1/2024	KeyCorp 3 of 5 stars	Boost Target	Overweight ➝ Overweight	$25.00 ➝ $28.00	+40.28%
3/1/2024	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Sector Outperform ➝ Sector Outperform	$33.00 ➝ $37.00	+80.05%
12/14/2023	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$25.00	+21.65%
6/15/2023	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target		$38.00 ➝ $30.00	+119.46%
6/5/2023	SVB Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target		$50.00 ➝ $35.00	+194.86%
6/5/2023	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target		$41.00 ➝ $32.00	+60.00%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 02:22 PM ET.

CSTL Forecast - Frequently Asked Questions

What is Castle Biosciences' forecast for 2024?: According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Castle Biosciences is $32.80, with a high forecast of $37.00 and a low forecast of $25.00.
Should I buy or sell Castle Biosciences stock right now?: 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Castle Biosciences in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CSTL shares.
Does Castle Biosciences's stock price have much upside?: According to analysts, Castle Biosciences's stock has a predicted upside of 51.26% based on their 12-month stock forecasts.
What analysts cover Castle Biosciences?: Castle Biosciences has been rated by research analysts at Robert W. Baird, and Stephens in the past 90 days.
Do Wall Street analysts like Castle Biosciences more than its competitors?: Analysts like Castle Biosciences more than other "medical" companies. The consensus rating for Castle Biosciences is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how CSTL compares to other companies.